chr6-7580146-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_004415.4(DSP):c.3956C>T(p.Thr1319Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,613,888 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1319S) has been classified as Likely benign.
Frequency
Consequence
NM_004415.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.3956C>T | p.Thr1319Ile | missense_variant | 23/24 | ENST00000379802.8 | |
DSP | NM_001319034.2 | c.3956C>T | p.Thr1319Ile | missense_variant | 23/24 | ||
DSP | NM_001008844.3 | c.3582+374C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.3956C>T | p.Thr1319Ile | missense_variant | 23/24 | 1 | NM_004415.4 | P2 | |
DSP | ENST00000418664.2 | c.3582+374C>T | intron_variant | 1 | A2 | ||||
DSP | ENST00000710359.1 | c.3956C>T | p.Thr1319Ile | missense_variant | 23/24 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250720Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135610
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461812Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 727200
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152076Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 23, 2017 | The p.Thr1319Ile variant in DSP has been reported in 1 individual with HCM, thou gh this individual carried a pathogenic MYBPC3 variant that is likely responsibl e for their disease (Bottillo 2016). This variant has been identified in 4/11121 0 of European chromosomes by the Genome Aggregation Database (gnomAD, http://gno mad.broadinstitute.org; dbSNP rs138599871). Computational prediction tools and c onservation analysis do not provide strong support for or against an impact to t he protein. In summary, the clinical significance of the p.Thr1319Ile variant is uncertain. - |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Dec 01, 2023 | This missense variant replaces threonine with isoleucine at codon 1319 of the DSP protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual with hypertrophic cardiomyopathy, who also carried a pathogenic variant in the MYBPC3 gene that could explain the observed phenotype (PMID: 26656175). This variant has also been observed in an individual with left ventricular noncompaction (PMID: 33500567). This variant has been identified in 4/250720 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Apr 25, 2023 | This missense variant replaces threonine with isoleucine at codon 1319 of the DSP protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual with hypertrophic cardiomyopathy, who also carried a pathogenic variant in the MYBPC3 gene that could explain the observed phenotype (PMID: 26656175). This variant has also been observed in an individual with left ventricular noncompaction (PMID: 33500567). This variant has been identified in 4/250720 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 31, 2019 | Reported in a patient with HCM who also harbored a pathogenic splice site variant in the MYBPC3 gene (Bottillo et al., 2016); Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID#504527; Landrum et al., 2016); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26656175) - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2022 | The p.T1319I variant (also known as c.3956C>T), located in coding exon 23 of the DSP gene, results from a C to T substitution at nucleotide position 3956. The threonine at codon 1319 is replaced by isoleucine, an amino acid with similar properties. This variant was detected in an individual with hypertrophic cardiomyopathy (HCM) who had additional cardiac variants, including a splicing mutation in MYBPC3 (Bottillo I et al. Gene, 2016 Feb;577:227-35), as well as in a left ventricular non-compaction (LVNC) cohort with limited clinical details (Mazzarotto F et al. Genet Med, 2021 05;23:856-864). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Woolly hair-skin fragility syndrome;C1843896:Arrhythmogenic right ventricular dysplasia 8;C1852127:Keratosis palmoplantaris striata 2;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma;C1864826:Lethal acantholytic epidermolysis bullosa;C4014393:Cardiomyopathy, dilated, with wooly hair, keratoderma, and tooth agenesis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 20, 2021 | - - |
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 11, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at